Cardiol Therapeutics Inc.
General ticker "CRDL" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $89.2M (TTM average)
Cardiol Therapeutics Inc. follows the US Stock Market performance with the rate: 7.4%.
Estimated limits based on current volatility of 3.3%: low 1.00$, high 1.07$
Factors to consider:
- Total employees count: 17 as of 2022
Short-term CRDL quotes
Long-term CRDL plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | CA$0.00MM | CA$0.00MM | CA$0.00MM |
| Operating Expenses | CA$30.49MM | CA$22.47MM | CA$40.28MM |
| Operating Income | CA$-30.49MM | CA$-22.47MM | CA$-40.28MM |
| Non-Operating Income | CA$7.68MM | CA$1.25MM | CA$3.60MM |
| R&D Expense | CA$13.99MM | CA$10.73MM | CA$14.01MM |
| Income(Loss) | CA$-22.82MM | CA$-21.22MM | CA$-36.68MM |
| Profit(Loss)* | CA$-30.93MM | CA$-28.13MM | CA$-36.68MM |
| Stockholders Equity | CA$38.51MM | CA$28.25MM | CA$24.73MM |
| Assets | CA$45.76MM | CA$36.70MM | CA$31.86MM |
| Operating Cash Flow | CA$-27.22MM | CA$-25.18MM | CA$-25.06MM |
| Capital expenditure | CA$0.07MM | CA$0.06MM | CA$0.02MM |
| Investing Cash Flow | CA$-0.07MM | CA$-0.06MM | CA$-0.02MM |
| Financing Cash Flow | CA$-0.05MM | CA$-0.06MM | CA$18.84MM |
| Earnings Per Share** | CA$-0.49 | CA$-0.44 | CA$-0.51 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.